The DNA-binding protein REST forms complexes with histone deacetylases (HDACs) to repress neuronal genes in non-neuronal cells. In differentiating neurons, REST is downregulated predominantly by transcriptional silencing. Here we report that posttranscriptional inactivation of REST by alternative splicing is required for hearing in humans and mice. We show that, in the mechanosensory hair cells of the mouse ear, regulated alternative splicing of a frameshift-causing exon into the Rest mRNA is essential for the derepression of many neuronal genes. Heterozygous deletion of this alternative exon of mouse Rest causes hair cell degeneration and deafness, and the HDAC inhibitor SAHA (Vorinostat) rescues the hearing of these mice. In humans, inhibition of the frameshifting splicing event by a novel REST variant is associated with dominantly inherited deafness. Our data reveal the necessity for alternative splicing-dependent regulation of REST in hair cells, and they identify a potential treatment for a group of hereditary deafness cases.
Correspondence botond-banfi@uiowa.edu In Brief A REST mutation impacting its alternative splicing disrupts gene expression in auditory hair cells, leading to deafness, and targeting REST's partners with HDAC inhibitors can rescue hearing in Rest mutant mice.
INTRODUCTION
Repressor Element-1 (RE1) motifs are 21-to 30-bp DNA sequences located predominantly in neuronal genes, and they serve as binding sites for the RE1-silencing transcription factor (REST), also known as neuron-restrictive silencing factor (NRSF) (Chong et al., 1995; Schoenherr and Anderson, 1995) . In non-neuronal cells, REST and its corepressors, coREST, histone deacetylase (HDAC)1, HDAC2, lysine-specific demethylase (LSD)1, and G9a methyltransferase (McGann et al., 2014) , are vital to the repression of RE1-containing genes. In mice, ubiquitous deletion of both Rest alleles (Rest À/À ) causes upregulation of neuronal transcripts in non-neural tissues and embryonic lethality (Chen et al., 1998) , and conditional deletion of both Rest alleles in the common progenitors of glia and neurons causes genomic instability and premature expression of neuronal transcripts (Nechiporuk et al., 2016) . Thus, REST plays two key roles in non-neuronal cells: repressing neuronal genes and protecting genomic stability. REST protein expression is reduced dramatically in differentiating neurons. Given that no gain-of-function mutation in REST has been identified in any species, in vivo assessments of the importance of such reductions have been based on the delivery of constitutively transcribed REST constructs into the CNS of mouse and chick embryos. In these studies, electroporation of CNS neurons with REST-encoding expression plasmids led to errors in commissural axon guidance in the spinal cord and stalled radial migration in the neocortex (Paquette et al., 2000; Mandel et al., 2011) .
Transcriptional repression is the main mechanism whereby REST is downregulated in differentiating neurons (Ballas et al., 2005) ; however, REST is also inactivated through alternative splicing of its pre-mRNA in both neurons and mechanosensory hair cells of the ear (Raj et al., 2011; Nakano et al., 2012) . The contribution of this splicing event to the reduction of REST activity was not determined in any tissue prior to this study, and its impact on organ function has not been evaluated.
Alternative splicing produces forms of the REST mRNA that either contain or lack exon 4. Incorporation of this exon into the REST mRNA requires SRRM4, a splicing regulator expressed selectively in neurons and hair cells (Calarco et al., 2009; Nakano et al., 2012) . Notably, the position of the splice acceptor site of exon 4 is not identical in all mammals, and thus the length of this exon is not uniform across species. In mice, exon 4 is a 16-nt frameshift-causing exon (Raj et al., 2011) (Figure 1A ), whereas in humans two alternative splice donor sites exist and two forms of the exon are produced (Palm et al., 1999) . Splicing of human REST at a donor site that is conserved between mice and humans produces a 50-nt exon with a stop codon (exon 4a), and splicing of human REST at a non-conserved donor site produces a 4-nt frameshifting microexon (exon 4b). Although all exon 4-containing REST transcripts encode inactive proteins that lack a repressor and three zinc-finger domains of the fulllength isoform (Magin et al., 2002) , exon 4 is rarely considered in analyses of the REST exon-intron structure, perhaps because none of the vertebrate genomes in the RefSeq database are annotated for it.
Here we set out to determine whether inactivation by alternative splicing is redundant with other mechanisms of REST regulation. We found that mice heterozygous for exon 4 deletion have no apparent CNS defects but lose all mechanosensory hair cells in the ear and fail to respond to sound. The exceptional sensitivity of the ear to exon 4 deletion correlated with the particularly high contribution of exon 4 splicing to REST downregulation in hair cells. Hair cells and hearing of exon 4-knockout mice were rescued by treatment with SAHA (Vorinostat), an FDA-approved inhibitor of HDACs. Finally, analysis of the cause of dominantly inherited deafness in humans whose hearing loss was linked to the REST-containing DFNA27 locus (Peters et al., 2008 ) revealed a novel variant of REST that prevented exon 4b-dependent inactivation of the encoded protein. Our data indicate that alternative splicing is essential for REST regulation in the inner ear and that defects in this mechanism can be offset by HDAC inhibitors.
RESULTS

Rest Exon 4 Is Necessary for the Development and Maintenance of Mechanosensory Hair Cells
We used homologous recombination in embryonic stem cells (ESCs) to generate mice heterozygous for a Rest allele in which exon 4 is flanked by loxP sites (Rest +/flEx4 ; Figures 1B, S1A, and S1B). RT-PCR analysis of the neocortex of homozygous Rest flEx4/flEx4 and wild-type (WT) mice demonstrated that insertion of loxP sites did not affect splicing of exon 4 into the mRNA ( Figures S1C and S1D ). An exon 4-deleted form of Rest (Rest DEx4 ) was created by crossing Rest flEx4/flEx4 mice to transgenic mice expressing Cre recombinase under the control of a ubiquitously active b-actin promoter (Figures 1B and S1E) . RT-PCR analysis of neural and non-neural tissues of Rest DEx4/DEx4 and WT mice confirmed that this deletion prevented production of the exon 4-containing splice form (Rest 4 ) without reducing expression of the form lacking this exon (Rest 4À ; Figures 1C and S1F).
Heterozygous Rest +/DEx4 mice exhibited balance defects and were deaf ( Figures 1D-1F ). Histological analysis of the inner ear of Rest +/DEx4 mice revealed that hair cells were present until embryonic day (E) 16-E17 but degenerated throughout the inner ear by post-natal day (P)12 ( Figures 1G, 1H , S1G, S1H, and S2). The autonomy of the hair cell defect was tested by intercrossing the Rest +/flEx4 mice to Gfi1 +/Cre mice, which express Cre selectively in hair cells (Yang et al., 2010) . As in the case of global heterozygous deletion of exon 4, hair cellspecific deletion of one copy of exon 4 led to the degeneration of hair cells ( Figure S1I ) and deafness (data not shown). Thus, Rest exon 4 is essential for hair cell development and this function is cell autonomous.
Next, we tested whether deleting one copy of Rest exon 4 when the ear is fully developed affects hearing. Rest flEx4/flEx4 mice were crossed to mice homozygous for a transgene encoding tamoxifen-inducible Cre recombinase in the Rosa26 locus (Rosa CreERT2/CreERT2 ), and the offspring were treated with tamoxifen or control vehicle from P40 to P47. One month later, measurement of auditory brainstem responses (ABRs) to various pure-tone stimuli revealed hearing loss in the tamoxifen-injected Rest +/flEx4 ;Rosa +/CreERT2 mice, but not in vehicle-injected mice of the same genotype ( Figure 1I ). Histological analyses of the inner ear of tamoxifen-injected Rest +/flEx4 ;Rosa +/CreERT2 mice revealed partial loss of hair cells (Figures 1J and S3A) , and PCR testing of the organ of Corti demonstrated that tamoxifen-dependent recombination occurred in some copies of the Rest flEx4 allele ( Figure S3B ), consistent with reports of mosaic Cre activation in other organs (Hameyer et al., 2007) . Thus, Rest exon 4 is critical for hair cell survival in both newborn and adult mice. Immunofluorescence analysis of the hearing organ of P6 Rest +/DEx4 mice revealed expression of the active form of the pro-apoptotic executioner caspase-3 in many hair cells (Figure S3C) . Activation of the apoptotic pathway was confirmed by the fact that the caspase inhibitors Z-DEVD-FMK and Z-VAD-FMK delayed the death of hair cells in organ of Corti cultures derived from Rest +/DEx4 mice. However, these inhibitors failed to prevent the degeneration of stereocilia (Figures S3D and S3E) , suggesting that the inhibition of apoptosis is insufficient to rescue hair cells of Rest +/DEx4 mice.
Although Rest is alternatively spliced in the developing neocortex, H&E staining of brain sections from Rest +/DEx4 mice did not reveal pathological alterations ( Figure S3F ). The lack of histological defects in the CNS was further supported by immunostaining of brain sections from newborn Rest +/DEx4 mice with antibodies against markers of various cortical layers ( Figures  S3G-S3I ), as well as by immunostaining of neural tubes of such mice with an antibody against the commissural axon marker TAG-1 ( Figure S3J ). Thus, Rest exon 4 is not essential for either radial migration in the neocortex or commissural axon pathfinding in the spinal cord. Figure 2A ). This intronic variant co-segregated with hearing loss in the LMG2 family ( Figure 2B ). The outcomes of three additional analyses were consistent with the notion that the C > G variant is pathogenic: the C nucleotide is conserved in all 80 genomes listed in the UCSC Genome Browser as containing a region similar to exon 4 of REST, the G variant is absent from the Genome Aggregation Database, and sequencing of 400 DNA samples (Coriell Human Diversity Panel) invariably detected C 21 bases upstream of exon 4a/b. Thus, a rare sequence variant in the third intron of REST co-segregates with hearing loss in the LMG2 family. The C > G variant causes an AC-to-AG change downstream of a polypyrimidine tract, a sequence combination that is the hallmark of splice acceptor sites. To determine whether the AG sequence affects REST splicing, we performed RT-PCR analysis of blood cell RNA for a control and 2 affected subjects. RT-PCR amplification of the exon 3-5 junction region of the REST mRNA produced a single product for the control subject but two for the affected subjects ( Figure 3A ). The longer product, which was observed only for the affected subjects, contained a mutant form of exon 4a (designated exon 4a M ) with an in-frame stop codon. The splice acceptor site of exon 4a M was at the variant AG sequence, and the splice donor site was identical to that of exon 4a ( Figure 3E ). The shorter product was identified as the amplicon of the WT REST 4À mRNA ( Figures 3A and 3B) . Thus, the C > G variant causes truncation of the coding region of REST in a non-neural tissue by generating a novel splice acceptor site for exon 4a. However, heterozygosity for the exon 4a M -dependent inactivation of REST is unlikely to explain the DFNA27 phenotype, because the hearing threshold of heterozygous Rest knockout (Rest +/À ) mice (Gao et al., 2011 ) is similar to that of WT littermates at P130 ( Figure S3K ). Thus, we tested the C > G DFNA27 variant for additional defects in REST pre-mRNA processing in the presence of SRRM4, which regulates alternative splicing of exon 4.
The Intronic C > G Variant Prevents SRRM4-Dependent Inactivation of REST Splicing of exon 4 into the REST mRNA is normally tissue specific and requires SRRM4, which is expressed selectively in neurons and hair cells. SRRM4 binds to pre-mRNAs at UGC motifs located between polypyrimidine tracts and downstream alternative exons (Nakano et al., 2012; Raj et al., 2014) , and when it does so the alternative exon is incorporated into the mature mRNA. We used minigenes to test the effects of SRRM4 on alternative splicing of the C > G DFNA27 variant of REST. WT and DFNA27 versions of the minigene were created by inserting REST exon 4a/b and its flanking introns, from a control subject and an affected subject, respectively, between two constitutively spliced exons ( Figure 3C , top). The nonneuronal cell line HEK293 was co-transfected with the minigene and either an SRRM4-encoding plasmid or an empty control expression vector. Splicing of the minigene-encoded transcript in transfected cells was analyzed by RT-PCR using primers that annealed to the constitutive exons of the minigenes. In the absence of SRRM4 expression, RNA encoded by the WT minigene contained only constitutive exons (splice form 4À) and RNA encoded by the DFNA27 minigene contained exon 4a M . In the presence of SRRM4, two splice forms were expressed from the WT minigene: one containing exon 4a and another containing the exon 4b microexon (Figures 3C-3E ). The ratio of exon 4a-and exon 4b-containing splice forms was approximately 6 to 1 in the transfected cells; a similar ratio of exon 4a-and exon 4b-containing REST transcripts was detected in human fetal brain ( Figures S3L and S3M ). In the presence of SRRM4, two RNA splice forms were also expressed from the DFNA27 minigene: an exon 4a M -containing form (longer), and a novel form that contained a 24-nt variant of exon 4b (i.e., exon 4b M ; shorter). The splice acceptor site of exon 4b
M was at the DFNA27-specific AG, and its splice donor site was identical to that of exon 4b ( Figures 3D-3F) . Thus, the splicing of exon 4b M required both C > G variant-dependent relocation of the splice acceptor site and an SRRM4-dependent shift in the splice donor site. Exon 4b M encodes 8 amino acids and does not alter the reading frame ( Figure 3E ). We hypothesized that inclusion of exon 4b M in the REST mRNA leads to the production of a functional REST 4bM protein. To test the gene repressor activity of each REST isoform, we co-transfected Neuro2a cells (which contain little endogenous REST) with it and a reporter of REST activity. The reporter contains an RE1 sequence upstream of a luciferase expression cassette ( Figure 3G ). Immunoblot analysis of the transfected cells demonstrated comparable expression of the REST isoforms ( Figure S3N ). Measurement of luciferase activity (Figure 3G) revealed that 2 of 5 isoforms were active: the REST 4À form, which was produced only in the absence of SRRM4; and the aberrant REST 4bM form, which was produced only in SRRM4-expressing cells and in the presence of the C > G DFNA27 variant. These data suggest that the C > G DFNA27 variant has opposing effects on REST depending on whether or not SRRM4 is present. In cells that do not express SRRM4, the C > G variant inactivates REST aberrantly by creating a novel acceptor site for constitutive splicing upstream of exon 4a/b. In cells that do express SRRM4, the C > G variant aberrantly leads to the production of active REST, because no stop codon
PhyloP conservation score based on the alignment of 100 vertebrate genomes
(A) Location and conservation of REST region containing a C > G variant in family LMG2. Top: schematic of exon-intron structure of REST from exon 3 to exon 5 is shown. Rectangles indicate exons 3 and 5 (black), exon 4a (red), and exon 4b (purple outline). Introns are shown as horizontal lines. Middle: chromatograms depict genomic sequences upstream of exon 4a/b in an unaffected and an affected heterozygous subject. In the affected subject, the wildtype C nucleotide in intron 3 of REST is replaced by a G (gray shading). First base of exon 4a/b is boxed. Bottom: vertebrate PhyloP conservation score is shown. (B) Pedigree of LMG2 family, showing co-segregation of progressive hearing loss with intronic C > G variant of REST. Filled symbols represent individuals with hearing loss; hearing data are not available for generation IV. Letters beneath symbols indicate nucleotides 21 bases upstream of REST exon 4 in the individual. Arabic numerals identify subjects whose RNA was analyzed ( Figure 3A ).
is present in the 24-base region between the C > G variantgenerated splice acceptor site and SRRM4-dependent splice donor site of exon 4b M . Our results strongly suggest that SRRM4-directed alternative splicing of exon 4 cannot inactivate REST in human subjects whose genome harbors the C > G DFNA27 variant.
The Rest
DEx4 Mutation Is Associated with Abnormally
High REST Activity in the Ear We used the Rest +/DEx4 mouse to identify exon 4-dependent alterations in the inner ear transcriptome at E15.5, a time corresponding to the onset of hair cell degeneration in the mutant mice ( Figure S2C ). RNA was isolated from the utricle, because in Rest +/DEx4 mice the onset of hair cell degeneration in this structure is more synchronous than in the cochlea. RNA sequencing (RNA-seq) analysis of utricular samples identified 357 genes that are differentially expressed in Rest +/DEx4 and WT mice (Figure 4A ; Table S1 ). Analysis of the same data for alternative splicing patterns of mRNAs other than Rest did not reveal differences between the two groups ( Figure S4A ). Thus, the Rest +/DEx4 genotype is associated with changes in utricular gene expression. To identify REST targets among the differentially expressed genes, we used a filtered set of REST chromatin immunoprecipitation sequencing (ChIP-seq) data from the Encyclopedia of DNA Elements (ENCODE) (STAR Methods), and we located REST-binding sites in 744 genes across the genome (Table  S2) . We refer to the 744 genes as high-confidence REST targets. Among 357 genes differentially expressed in the utricles of WT and Rest +/DEx4 mice, 64 were high-confidence REST targets (red bars in Figure 4A ; Table S1 ). The set of high-confidence REST target genes represented 25% of all genes that are expressed at reduced levels in the utricles of Rest +/DEx4 mice;
such genes represent only 3.6% of all genes expressed in hair cells ) (Fisher's exact test, p < 0.0001; further analyses in Figures S4B and S4C) . Thus, the expression of several high-confidence REST targets is abnormally low in the utricles of Rest +/DEx4 mice at the onset of hair cell degeneration. Searches of various genotype-phenotype databases (Table S1 ) revealed that disorders of hearing or balance have been linked to 31 of the genes that we found to be differentially expressed in the utricles of Rest +/DEx4 and WT mice ( Figure 4A ). Furthermore, 20 of these are required specifically for hair cell development and function (Table S1 ). Thus, incorporation of exon 4 into Rest is necessary for the regulation of several genes that encode proteins critical for the development and function of hair cells.
Heterozygous Deletion of Rest Exon 4 Causes Defects in the Cilia of Utricles
Our analysis of Uniprot keyword annotations of genes expressed at reduced levels in the utricles of Rest +/DEx4 mice revealed the lowest p values to be associated with the keywords synapse and cilium ( Figure 4C ). Although REST was known to regulate the expression of many synaptic proteins (Ballas et al., 2005) , it had not been linked to ciliogenesis. A review of genes associated with the keyword cilium showed that 12 stereocilium-related and 37 kinocilium-related genes are expressed at reduced levels in the utricles of Rest +/DEx4 mice (Table S1 ). High-confidence REST targets were more frequent among the stereociliumrelated (25%) versus kinocilium-related (8%) genes. Given that RFX2-4 and RFX7 regulate the transcription of many kinocilium-related genes (Manojlovic et al., 2014) , we examined the differentially expressed genes and all hair cellexpressed genes for evolutionarily conserved sequences similar indicate differences in expression levels of genes known to be important for hearing or balance. Names of all differentially expressed genes are listed in Table S1 . and WT mice at E16. For two kinocilia, tip (arrow) and base (arrowhead) are indicated in lower panels. Scale bar, 10 mm. (E and F) Violin plots of lengths of kinocilia (E) and maximum lengths of stereocilia bundles (F) Figure S4C ). Although Rfx7 is not a high-confidence REST target, an RE1-like sequence from this gene conferred REST-dependent repression to a reporter ( Figures S4F and S4G ). These data are consistent with REST modulating the expression of an RFX family transcription factor in the ear.
We next examined cilia in the utricles of Rest +/DEx4 and WT mice at E15 and E16. Stereocilia were identified by F-actin staining, and kinocilia were labeled using an antibody against acetylated a-tubulin. Confocal microscopy revealed that both organelles were abnormally short in the utricles of Rest
mice at E15 and E16 ( Figures 4D-4F) . Thus, the abnormally low expression of many stereocilium-and kinocilium-related genes in the utricles of Rest +/DEx4 mice is associated with the shortening of both organelles.
Contributions of Alternative Splicing and Transcriptional Repression to REST Downregulation Differ between Hair Cells and Cortical Neurons
We assessed the effect of the Rest DEx4 mutation on gene expression in the neocortex, which we selected as a reference neural tissue. RNA-seq analysis of neocortices of E15.5 WT and Rest +/DEx4 mice revealed differential expression of 100 genes ( Figure 4B ). Among these, 15 were high-confidence REST targets, and expression of 10 of the 15 was moderately (i.e., <2-fold; Table S4 ) reduced in the Rest +/DEx4 neocortex. For high-confidence REST targets randomly selected from the cortical and utricular RNA-seq datasets, qRT-PCR analysis at additional time points demonstrated that expression in the Rest +/DEx4 neocortex was reduced at E16, but not P6 and P16
( Figure S4H ). In contrast, expression in the utricle and saccule was reduced even at P16 following tamoxifen-induced deletion of exon 4 at P7-P9 ( Figures S4H and S4I ). These data suggest that the impact of exon 4 splicing on the expression of highconfidence REST targets differs between hair cells and cortical neurons, with respect to both magnitude and duration.
RT-PCR analysis of Rest exon 4 splicing showed that, whereas the Rest 4 :Rest 4À ratio declined between E16 and P16 in the neocortex, it did not decline after birth in the inner ear ( Figure 5A ). Figure 5B ). The activity of the transgenic Rest promoter was evaluated based on the intensity of EGFP immunofluorescence in sections of the neocortex and inner ear. Neurons and hair cells were identified using anti-NeuN and anti-MYO7A antibodies, respectively. In cortical sections from P0 transgenic mice, the EGFP signal varied among individual neurons, representing from 2% to 60% of the EGFP signal in non-neurons. By P16, the neuronal EGFP signal was reduced to 0.4%-7% of that in non-neurons ( Figures 5C and 5E ). In the ear, the EGFP signal in inner hair cells (IHCs) and utricular hair cells at both P0 and P16 was still 50% that in non-hair cells (non-HCs; Figures  5D and S4J) ; in outer hair cells (OHCs) the signal increased between P0 and P16 ( Figure 5E ). These data suggest that promoter-dependent downregulation of Rest is much stronger in cortical neurons than hair cells. 4 , and the exon junction regions of several cell-type-specific transcripts (for assignment of cell type). This analysis revealed that at P7 total Rest expression was comparable in non-HCs, IHCs, and OHCs, whereas at P1 it was comparable in only non-HCs, IHCs, and a subset (70%) of OHCs ( Figure 5F ). In the remaining 30% of P1 OHCs the Rest mRNA was undetectable. This analysis also revealed that 94% of Rest-expressing hair cells, but fewer than 1% of non-HCs, contained the Rest 4 splice form ( Figure 5F ). form, but in non-HCs Rest 4À was the only detected splice form. Thus, although the Rest gene is transcribed in all IHCs and OHCs by the end of the first post-natal week, expression of the exon 5-encoded segment of REST, which is critical to its repressor activity, was minimal due to the incorporation of exon 4 into the transcript. Overall, our expression data reveal differences in the regulation of REST in hair cells versus cortical neurons: transcriptional silencing is the predominant form of REST downregulation in cortical neurons, and alternative splicing (inclusion of exon 4) is the main mechanism of REST inactivation in hair cells.
HDAC Inhibitors Rescue OHCs of Rest Exon 4-Deficient Mice in Organ Cultures
Considering that HDAC1 and HDAC2 are critical for RESTdependent gene repression (McGann et al., 2014), we examined the ability of HDAC inhibitors to modulate REST activity. We tested three inhibitors: FK228 (HDAC1-3, 10, and 11 selective) (Ganesan, 2015) , SAHA (pan-HDAC), and Merck60 (HDAC1 and HDAC2 selective) (Methot et al., 2008) . In HEK293 cell cultures, all three inhibitors increased the expression of nearly all eight REST targets that were selected for qRT-PCR analysis based on reduced expression of their orthologs in the ear and brain of the Rest +/DEx4 mouse ( Figure S5A ). Thus, the effects of FK228, SAHA, and Merck60 on the expression of REST target genes were similar to those of splicing exon 4 into Rest.
We used an organ culture system to test the effects of all three HDAC inhibitors on the hair cells of Rest +/DEx4 mice. Organ of Corti cultures from P1 Rest +/DEx4 and WT mice were incubated with 2 nM FK228, 1 mM SAHA, 1.2 mM Merck60, or solvent (non-treated group) from the second day in vitro (DIV2) to DIV8. F-actin staining of these cultures at DIV9 revealed that, whereas in non-treated organ cultures from Rest +/DEx4 mice the stereocilia of most OHCs degenerated, in HDAC inhibitor-treated cultures from the same mouse line most OHCs retained stereocilia ( Figures 6A, 6B , and S5B). Thus, HDAC inhibitors prevented the degeneration of OHCs of Rest +/DEx4 mice in vitro.
Next, we analyzed the effects of FK228 on the transcriptomes of organ of Corti cultures. FK228 was selected for this experiment for two reasons: it inhibits fewer HDACs than SAHA, and it is available from multiple commercial resources while Merck60 is not. RNA-seq analysis of FK228-treated and non-treated organ of Corti cultures from Rest +/DEx4 and WT mice revealed treatment-dependent alterations in the expression of $8,000 genes, independent of the genotype of the mouse of origin (Table S5) . Among these genes, and also among the genes that were differentially expressed in the utricles of Rest +/DEx4 and WT mice, S6D ). PCR analysis of the same cultures confirmed that tamoxifen induced recombination of loxP sites in nearly all copies of the Rest +/flEx4 allele, independent of whether an HDAC inhibitor was present ( Figure S6C ). Thus, both IHCs and OHCs in Rest exon 4-deficient organ of Corti cultures can be rescued by exposure to HDAC inhibitors.
We assessed the effects of SAHA on the hearing of mice in which exon 4 was deleted post-natally. Rest +/flEx4 ;Rosa
and WT mice were injected subcutaneously with tamoxifen or vehicle from P7 to P9 and also with SAHA or vehicle daily from P7 to P15 ( Figure 6F ). At P16, hearing was tested using puretone stimuli and ABR recordings. The ABR analysis revealed that SAHA reduced the tamoxifen-dependent shift in hearing threshold of Rest +/flEx4 ;Rosa +/CreERT2 mice at low sound frequencies ( Figure 6G ). Histological analysis of cochleas of the same mice demonstrated that SAHA reduced the extent of tamoxifen-dependent hair cell loss ( Figures 6F and S6E) . In WT mice, tamoxifen affected neither hearing nor the survival of hair cells. Thus, SAHA alleviated the cochlear defects associated with the deletion of Rest exon 4.
Given that SAHA was more effective in rescuing the OHCs of Rest exon 4-deficient mice at P6 than P16 ( Figures 6D and 6F) , we tested the effects of SAHA injection on acetylation of histone H4 in OHCs at P6 and P16. Immunofluorescence analysis showed that SAHA injection led to an increase in H4 acetylation at both time points; however, at P6 the magnitude of the increase was $6-fold larger than at P16 ( Figure S6F ). In rodents the BPB develops between P4 and P14 (Suzuki et al., 1998) , and thus hair cells may be more accessible to systemically delivered SAHA at P6 than P16.
DISCUSSION
Here we identify REST as a novel deafness gene in humans, and we show that the deafness-causing variant prevents inactivation of the REST protein by alternative splicing. We also show that a mouse model of the REST splicing defect is characterized by deafness and degeneration of mechanosensory hair cells, and we demonstrate that both hair cells and hearing can be partially rescued in these mice by applying the HDAC inhibitor SAHA. Overall, our data indicate that alternative splicing is critical for REST inactivation in hair cells and that defects in this mechanism can be offset by chemical inhibition of HDACs.
Although mutations in the constitutively spliced exons of REST have been linked to cancer and gingival fibromatosis (Mahamdallie et al., 2015; Bayram et al., 2017) , ours is the first study to associate REST with hearing loss, and DFNA27 is the first genetic variant shown to affect the alternative splicing of REST. The effects of the DFNA27 variant are highly unusual in that either gain or loss of function of the encoded protein occurs depending on the cellular context. In cells expressing the splicing factor SRRM4, the variant prevents REST inactivation by alternative splicing (gain of function), whereas in cells lacking SRRM4 it causes REST inactivation (loss of function). Our study suggests that the gain-of-function effect of DFNA27 is deafness causing because selective prevention of alternative splicingdependent inactivation of mouse REST also leads to deafness (Figure 1 ). In addition, in mice heterozygous for deletion of the first coding exon of Rest (Rest +/À ), the hearing threshold is similar to those of WT littermates, at least until P130 ( Figure S3K ). Thus, heterozygosity for loss-of-function mutations in REST may not impair hearing in humans.
Our results provide a plausible explanation for an apparent discrepancy: DFNA27-associated hearing loss is postlingual and progressive, yet Rest +/DEx4 mice are deaf by the time of normal hearing onset (i.e., P12-P16). Specifically, our results indicate that, whereas the mouse Rest DEx4 mutation completely prevents exon 4-dependent inactivation of the encoded protein, the human DFNA27 variant prevents exon 4b-dependent inactivation of REST without inhibiting exon 4a-dependent truncation of the encoded protein.
Our data shed new light on Srrm4 regulation in the ear. Although Srrm4 is repressed by REST in several cell types (Raj et al., 2011) utricle are either high-confidence REST targets or potential RFX targets. Whereas most of high-confidence REST targets are transcribed selectively in neurons and hair cells, many of the potential RFX target genes encode kinocilium-related proteins that are not expressed in neurons. Given that nearly all of these kinociliumrelated genes lack high-confidence binding sites for REST and are co-expressed with Rest in multi-ciliated epithelia, we suggest that the effect of REST on these genes in hair cells is indirect and cell type specific.
DFNA27 is the first example of a non-syndromic, deafnesscausing gene defect whose consequences can be ameliorated in a model organism by applying SAHA, an FDA-approved compound for the treatment of cutaneous T cell lymphomas (Mann et al., 2007) ; however, many other HDAC inhibitors have been developed. Some of those that were developed most recently and are not yet commercialized have better tissue penetration and HDAC1 and HDAC2 selectivity than SAHA (Wagner et al., 2015) . We suggest that these compounds hold promise for providing therapeutic benefits in cases of progressive hearing loss caused by gain-of-function mutations in REST.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Human Subjects
All human subjects-related procedures were approved by the Combined Neuroscience Institutional Review Board at the National Institutes of Health (NIH), Bethesda, MD, USA. Written informed consent was obtained from all participants. Venous blood was collected from the study subjects for DNA and RNA isolations. The ages of subjects were between 14 and 72 at the time of blood collection. The number and gender of participating subjects are shown in Figure 2B . Audiometric data for the participating subjects were described previously (Peters et al., 2008) .
Mice
All mouse procedures were approved by the University of Iowa Institutional Animal Care and Use Committee. Mice were housed in groups in temperature controlled rooms (21 ± 2 C) with 12 h/12 h light/dark cycle. Food and water were available for the mice ad libitum. Animal husbandry and health status monitoring were provided by the Office of Animal Resources staff at the University of Iowa. The ages of tested mice are indicated in the figure legends. The sexes of pre-weaning mice were not determined. Figure S6A . In the Gfi1 Cre allele, the Cre-encoding sequence replaces the protein-coding region of Gfi1. We refer to the Gfi1
Cre/Cre mice as Gfi1 À/À to emphasize that the goal was the inactivation of both Gfi1 alleles in Figure S6A as opposed to the expression of the Cre recombinase. Table S6 ) and Southern blotting, in both ES cells and Rest +/flNeoEx4 mice. For Southern blot analysis, genomic DNA was digested with the EcoRI, SpeI or BglII restriction endonuclease (New England Biolabs). Electrophoretically separated digestion products were transferred to positively charged nylon membranes (Roche) and hybridized with digoxigenin-labeled probes. Three probes were designed: one from the neomycin-resistance gene (Neo) of the targeting construct, and two from genomic regions that flank the targeted segment of Rest ( Figure S1A ). Digoxigeninlabeled nucleotides were incorporated into the probes using the DIG DNA Labeling and Detection Kit (Roche). The same kit was also used for the visualization of hybridized probes, following the manufacturer's instructions. Cre recombinase activity was induced using one of two regimens of injections with (Z)-4-hydroxytamoxifen (Tocris Bioscience), depending on the age of the mice: P7-9 mice were subcutaneously injected with (Z)-4-hydroxytamoxifen (33 mg/kg body weight) daily for 3 days; P40-47 mice were intraperitoneally injected with (Z)-4-hydroxytamoxifen (33 mg/kg body weight) daily for 8 days.
Cell Lines and Tissue Culture HEK293 cells (female) and Neuro2a cells (male) were obtained from the American Type Culture Collection (ATCC). HEK293 cells were grown in Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12 from Corning). Neuro2a cells were grown in DMEM (Corning). Both DMEM/F12 and DMEM were supplemented with 10% fetal bovine serum (FBS from Atlanta Biologicals), penicillin (100 units/mL; Thermo Fisher Scientific), and streptomycin (100 mg/mL; Thermo Fisher Scientific). Organs of Corti were dissected from P0-P5 mice and placed on Matrigel-coated transwell plates (Corning). The sexes of these mice were not determined. Organ cultures were maintained in neurobasal-A medium supplemented with B-27, N-2, 0.5 mM L-glutamine (all from Thermo Fisher Scientific), and 100 U/mL penicillin (Sigma). The culture medium was replaced on the organs once in every 3 days. Organ cultures and cell lines were grown at 37 C in the presence of 5% CO 2 .
METHOD DETAILS Hearing and Balance Tests
The ABR thresholds of mice were measured using a previously described open-field system, and both broadband and pure-tone stimuli (Nakano et al., 2012) . The ability of mice to balance (P21-28) was evaluated by measuring the time each mouse could remain on a fixed horizontal rod (1.8 cm in diameter) following two training trials.
Isolation and Analyses of DNA and RNA Genomic DNA was extracted from human blood samples as described previously (Peters et al., 2008) . To analyze the DFNA27 interval in the genomic DNA, two sets of PCR primers were designed. The first set was designed to amplify all annotated exons at the DFNA27 locus and all conserved intronic segments in REST. The second set was designed specifically for the amplification of the exon 4-containing region of REST (see primers in Table S6 ). The PCR amplicons were Sanger sequenced using BigDye Terminator chemistry and an ABI3730 DNA Analyzer (Applied Biosystems). RNA was isolated from human blood samples using the PAXgene Blood RNA Kit (QIAGEN), and was reverse transcribed using SuperScript III reverse transcriptase (Thermo Fisher Scientific). The cDNA products were analyzed for the presence of REST splice variants by PCR (see primers in Table S6 ). The PCR products were separated by size and sub-cloned into the pCR-TOPO vector (Thermo Fisher Scientific). A total of 180 clones were sequenced using the Sanger method. For the isolation of cortical RNA from mice, the neocortex was dissected from the brain and homogenized in Trizol Reagent (Thermo Fisher Scientific). RNA was extracted from the homogenized tissue with chloroform, and precipitated with isopropanol. RNA was dissolved in water, incubated with DNase, and further purified on the separation column of the RNeasy Mini Kit (QIAGEN), following the manufacturer's instructions. RNA was isolated from vestibular maculas and HEK293 cells using either the RNeasy Micro or Mini Kit (QIAGEN), depending on the number of cells in the samples. RNA samples from mice and HEK293 cells were reverse transcribed using SuperScript IV reverse transcriptase (Thermo Fisher Scientific). Human spleen RNA and fetal brain RNA were purchased from Clontech Laboratories, and were reverse transcribed using either SuperScript IV or ThermoScript (Thermo Fisher Scientific). The ratio of the detected splice forms of REST was not affected by the choice of reverse transcriptase (data not shown). The cDNA samples produced were analyzed by PCR and qPCR (see primers in Table S6 ). PCR products less than 200 bp in length were separated in polyacrylamide gels; larger PCR products were separated in agarose gels.
Immunofluorescence and Histochemistry
The antibodies used for this study are listed in the Key Resources Table. Whole-mount preparations of cochlear and vestibular tissues were fixed with 4% paraformaldehyde in PBS (4% PFA), and labeled with an anti-MYO7A antibody, an anti-H4ac antibody, an anti-acetylated-a-tubulin antibody, an anti-cleaved CASP3 antibody, or phalloidin-Alexa 488. The binding of primary antibodies to the specimens was tested using Alexa 488-conjugated, Alexa 568-conjugated, or Alexa 594-conjugated secondary antibodies. Rest promoter activity was examined in cortical and inner ear tissues using Rest promoter-EGFP transgenic mice. These mice were transcardially perfused with 4% PFA while under deep anesthesia. Inner ears and brains were dissected from the perfused mice, cryoprotected in sucrose solutions, embedded into Tissue Freezing Medium (Electron Microscopy Sciences), and cryosectioned. Sections were incubated with Alexa 488-conjugated anti-GFP antibody in combination with an Alexa 568-conjugated anti-MYO7A antibody or an Alexa 568-conjugated anti-NeuN antibody. The specificity of GFP detection was confirmed by probing inner ear and brain sections of WT mice with the Alexa 488-conjugated anti-GFP antibody. The APEX Antibody Labeling Kit (Thermo Fisher Scientific) was used for the conjugation of Alexa dyes to the antibodies. Layering of the neocortex was examined in P0 mice. Brain samples were fixed with 4% PFA, cryoprotected in sucrose solution, and embedded into Tissue Freezing Medium (Electron Microscopy Sciences). Cryosections were co-labeled with a mouse anti-SATB2 antibody and a rabbit anti-TBR1 antibody, or a mouse anti-NeuN antibody and a rabbit anti-PAX6 antibody. The binding of primary antibody was visualized with Alexa 488-and Alexa 594-conjugated secondary antibodies. For the labeling of commissural axons, mouse embryos (E11.5) were fixed with Prefer (Anatech) and processed for cryosectioning as described for the brain samples. Transverse sections of the rostral region of the spinal cord were probed with an anti-TAG1 antibody and an Alexa 488-conjugated secondary antibody. Images of fluorescently labeled tissues were acquired using an LSM 880 confocal microscope (Carl Zeiss) and analyzed using the ZEN lite 2012 software (Carl Zeiss) or ImageJ. For histochemical analysis of the brain, mice were transcardially perfused with 4% PFA while under deep anesthesia, after which the brain was dissected from the skull, embedded into paraffin, sectioned, and stained with H&E.
Single Cell RT-PCR Cochleas were dissected from either CD-1 or Gfi1 +/Cre ;Rosa +/CAG-tdTomato knock-in mice at P1 and P7 (the sexes of these mice were not determined). The organ of Corti-containing regions were dissected from the cochlea in ice-cold DMEM/F-12, and epithelia were removed from underlying mesenchyme following a 10-min treatment with 0.2 mg/mL thermolysin (Sigma) and 1.67 mg/mL DNase I (Stem Cell Technologies) at 37 C. Cochlear epithelial sheets containing hair cells, supporting cells, and some surrounding non-sensory cells were dissociated by 15 min digestion with TrypLE Select (GIBCO) or papain (Worthington) at 37 C and by trituration at 5-min intervals during the digestion. Enzymatic digestions were quenched with an equal volume of ice-cold DMEM/F-12 containing 10% FBS, and nuclei were stained with 1 mg/mL Hoechst 33342 (Thermo Fisher Scientific). Dissociated cells were pelleted and resuspended in the volume of DMEM/F-12 necessary to achieve a cell concentration of $500 cells/mL. cDNA was prepared from individual cells, and specific targets were pre-amplified using the Fluidigm C1 platform and either small (5-10 mm) or medium-sized (10-17 mm) integrated fluidic chips (Fluidigm), following the manufacturer's instructions. All capture sites of the integrated fluidic chips were imaged prior to cell lysis to identify the wells that contained viable single cells. Initial captures with non-transgenic mice were stained with 4 mM Calcein AM dye (Thermo Fisher Scientific), to confirm cell viability based on esterase activity in the cytoplasm. Primers for pre-amplification and qPCR were designed with the NCBI Primer-BLAST tool or adopted from a previous study (Burns et al., 2015) . Primer combinations were checked for multiplex primer dimerization using the Multiple Primer Analyzer Tool (Thermo Fisher Scientific). Single-cell cDNA samples were analyzed by qPCR on the Fluidigm BioMark HD platform (see primers in Table S6 ). The limit of detection (LOD) was set to Ct value 24, and expression data are reported as Log2 expression (Log2Ex) = LOD -Ct. qPCR assays were validated using a mouse universal cDNA library and a P1 mouse cochlear cDNA library, as described previously (Burns et al., 2015) . Assay efficiencies were calculated as 10 (À1/slope) -1 using a three-fold dilution series of pre-amplified cDNA. All assays used in this study had efficiencies between 0.926 and 1.124. Based on the expression data, cell IDs were grouped using unsupervised hierarchical clustering function of the SINGuLAR Analysis Toolset (Fluidigm) in R 3.0.2. The hair-cell representing cluster was identified based on the high average Log2Ex of 10 hair cell-specific transcripts (i.e., Chgb, Gfi1, Myo15, Pvalb, Scg3, Scn3b, Snap25, Srrm3, Srrm4, and Myo7a) across the cells . The 'non-hair cell' representing cluster was identified based on the low average expression of the 10 genes. In the hair-cell cluster, IHCs were identified based on the expression of Fgf8 (Log2Ex > 6) and the lack of expression of Slc26a5 (Log2Ex = 0). OHCs were identified based on the expression of Slc26a5 (Log2Ex > 4 at P1 and Log2Ex > 10 at P7) and the lack of expression of Fgf8 (Log2Ex = 0). Cells in which both Fgf8 and Slc26a5 were detected were excluded from analysis.
Cloning Procedures
The Rest exon 4-targeting construct was assembled in the pBlueScript vector. The left arm, floxed region, and right arm of the targeting construct was amplified by PCR using the mouse BAC clone RP23-27L14 (Children's Hospital Oakland Research Institute) as template. Restriction sites were incorporated into the amplified DNA segments via PCR primers (Table S6 ). The Neo cassette was obtained from GeneBridges. The completed targeting construct was excised from pBlueScript by restriction digestion, and ES cells were electroporated with it. REST minigenes were generated by subcloning PCR-amplified exon 4 and its flanking introns ($350 bp in both directions), from a control subject and a DFNA27 subject, between two constitutively spliced exons in the pET-01 vector (Mobitec). For production of the REST reporter gene, the canonical RE1 motif was fused to the proximal end of the thymidine kinase promoter (TK) from the pGL4.54 plasmid (Promega), using overlap extension PCR. The RE1-like sequence from the mouse Rfx7 gene (Rfx7-RE1L, chr9:72,606,074-72,606,107; GRCm38/mm10 assembly) was inserted distal of the TK promoter in a synthetic gene block DNA (Integrated DNA Technologies). The RE1-TK and TK-Rfx7-RE1L DNA fragments were subcloned into the multiple cloning site of the promoterless firefly luciferase-encoding vector pGL4.10 (Promega) to generate the RE1-TK-pGL4.10 and TK-Rfx7-RE1L-pGL4.10 plasmids. The negative-control reporter gene TK-pGL4.10 was generated by subcloning the TK promoter (without an RE1) into the pGL4.10 vector. Mutant version of the TK-Rfx7-RE1L-pGL4.10 reporter was generated by changing the 'TCC' and 'GGT' triplets of the RE1L motif to 'TTT' in a synthetic gene block and subcloning it into pGL4.10. Human SRRM4 and various isoforms of human REST were amplified by RT-PCR (see primers in Table S6 ) and subcloned into the pcDNA3.1+ or pLPC (Westbrook et al., 2008) expression vector.
Splicing Assays in Transfected Cells
HEK293 cells were co-transfected with the REST minigene (WT or DFNA27 version) and an SRRM4-encoding plasmid using Lipofectamine LTX and PLUS reagent (Thermo Fisher Scientific). In some experiments, the SRRM4-encoding plasmid was replaced with an empty pcDNA3.1+ expression vector (negative control). RNA was isolated from the cells 24 h after transfection using RNeasy Mini Kit (QIAGEN). The splicing of minigene-encoded transcripts was tested by RT-PCR (see primers in Table S6 ).
qRT-PCR Analysis of HDAC Inhibitor-Incubated Cells HEK293 cells were incubated with SAHA (1 and 5 mM), FK228 (2 and 10 nM), Merck60 (0.6 and 1.2 mM), or DMSO (0.1%, negative control) for 36 h. During incubation with HDAC inhibitors and 0.1% DMSO, the FBS concentration in the culture medium was changed from 10% to 2% to reduce the potential binding of HDAC inhibitors to serum proteins. At the end of the 36-h incubation time, RNA was isolated using RNeasy Mini Kit (QIAGEN). The expression levels of selected REST target genes and the reference gene G6PD were analyzed using qRT-PCR (see primers in Table S6 ).
Reporter Gene-Based Assays and Immunoblotting Neuro2a cells were transfected with the luciferase-encoding plasmids RE1-TK-pGL4.10 (firefly luciferase) and pGL4.7Rluc (renilla luciferase, 10:1 ratio of the two constructs), and expression vectors encoding the WT or DFNA27 forms of REST. Both flag-tagged and non-tagged forms of the various REST forms were tested. The presence of N-terminal flag tag did not affect the results of the assay (data not shown). In another set of experiments, Neuro2a cells were transfected with TK-Rfx7-RE1L-pGL4.10 and pGL4.7Rluc (10:1 ratio) or TK-Rfx7-RE1L MUT -pGL4.10 and pGL4.7Rluc (10:1 ratio), and an expression vector encoding WT REST 4-. Cells were lysed 36 h after transfection. The activities of firefly and renilla luciferases in the lysates were measured using the Dual-Luciferase Reporter Assay (Promega) and a luminometer (Wallac 1420 Multi-label Counter, PerkinElmer Life Sciences). Expression levels of WT and DFNA27 isoforms of REST were tested in transfected Neuro2a cells using immunoblotting. Cells were lysed in SDS sample buffer, boiled for 3 min, resolved by SDS-PAGE, and electroblotted onto nitrocellulose membranes. Following a blocking incubation step, monoclonal anti-flag antibody (diluted 1:1,000) or rabbit anti-LMNB1 antibody (diluted 1:5,000) was added to the membranes for 14 hours. After multiple washing steps, membranes were incubated with HRP-conjugated anti-mouse antibody (diluted 1:10,000) or HRP-conjugated anti-rabbit antibody (diluted 1:10,000). Immunoblot signals were visualized using SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific).
Incubation of Organ of Corti Cultures with HDAC Inhibitors
To analyze the effects of HDAC inhibitors on the survival of cochlear hair cell in vitro, organ of Corti cultures were incubated with SAHA (1 mM), FK228 (2 nM), Merck60 (1.2 mM), or DMSO (0.1%) from DIV2-3 to DIV9-12. SAHA was added to the cultures every 12 h because its half-life in serum is only 1-2 h (Konsoula and Jung, 2008). FK228 was added to the organ cultures once in every 3 days for 12 h; the medium was exchanged at the end of the 12-h incubation to prevent cytotoxicity associated with the prolonged presence of FK228. The Merck60-containing medium was exchanged daily because the half-life of Merck60 in aqueous solutions has not been reported. Some of the organ cultures were also treated with 5 mM (Z)-4-hydroxytamoxifen (Tocris Bioscience) on DIV3-4 to induce Cre activity. On DIV9 or DIV12, the organ cultures were fixed with 4% PFA and labeled with phalloidin-Alexa 488 or immunostained as described in the 'Immunofluorescence and Histochemistry' section. To test the efficiency of tamoxifen-induced recombination of loxP sites in vitro, DNA was isolated from a subset of cultures at DIV12 using PicoPure DNA Extraction Kit (Thermo Fisher Scientific). The isolated DNA was analyzed using PCR (see primers in Table S6 ). To analyze FK228-dependent gene expression changes, organs of Corti were dissected from newborn mice and incubated with 2 nM FK228 or solvent only (0.1% DMSO) from DIV1 to DIV1.5 and from DIV3 to DIV3.5. RNA was isolated from these cultures at DIV3.5.
RNA Sequencing and Bioinformatics Analyses
The neocortex of 3 WT and 3 Rest +/DEx4 mice (E15.5) was dissected from the brain, and RNA was isolated from the dissected tissue using Trizol Reagent (Thermo Fisher Scientific). RNA was further purified on the separation column of the RNeasy Mini Kit (QIAGEN), following the manufacturer's instructions. Utricles were dissected from E15.5 WT and Rest +/DEx4 mice, and RNA was isolated from the dissected tissue using the RNeasy Micro Kit (QIAGEN). RNA was pooled from 7-9 mice to obtain a single sample with sufficiently high concentration for RNA-seq. In total, 25 WT mice (n = 3 samples) and 32 Rest +/DEx4 mice (n = 4 samples) were used for the RNAseq experiment. The RNeasy Micro Kit (QIAGEN) was used for the isolation of RNA from organ of Corti cultures that were incubated with 2 nM FK228 or solvent. RNA was pooled from 6-8 organ of Corti cultures to obtain a single sample for RNA-seq. In total, 28 WT mice (n = 4 FK228-treated and 4 control samples) and 29 Rest +/DEx4 mice (n = 4 FK228-treated and 4 control samples) were used for the RNA-seq experiment. All RNA samples were processes for RNA-seq following identical protocol. 200-300 ng of total RNA were reverse transcribed using SuperScript IV reverse transcriptase (Thermo Fisher Scientific), oligo dT primer, and template switching oligo. Second strand cDNA was amplified using LongAmp DNA polymerase (New England BioLabs) for 12 PCR cycles, purified on SPRI Select Beads (Beckman Coulter), and eluted with Buffer EB (QIAGEN). The size distribution and concentration of second strand cDNA was evaluated using High Sensitivity Large Fragment Analysis Kit and a Fragment Analyzer instrument (both from Advanced Analytical). 125 pg of second strand cDNA was tagmented, PCR amplified, and indexed using the Nextera XT Library Prep Kit (Illumina). Following AMPure XP bead purification (Beckman Coulter), the size distribution and concentration of cDNA Libraries were evaluated using High Sensitivity NGS Fragment Analysis Kit (Advanced Analytical) and Fragment Analyzer. All libraries were normalized, pooled and sequenced in a HiSeq1500 instrument (126 3 126 paired end mode; Illumina). Demultiplexed samples were mapped to the mouse genome (GRCm38.p4 Release M11 from GENCODE), and transcripts were quantified using the STAR aligner (v2.5.2a) and the '-quantMode GeneCounts' parameter (Dobin et al., 2013) . Gene level counts were filtered to remove genes that had lower than 5 counts in all compared samples. Differential gene expression was evaluated using the DESeq2 tool (Love et al., 2014) . Genes were considered differentially expressed if the adjusted p in the DESeq2 analysis was lower than 0.05. Only the RefSeq curated genes were analyzed, and pseudogenes were filtered out. The UCSC Table Browser ( Karolchik et al., 2004) was used for the genome-wide analysis of REST ChIP-seq peaks from ENCODE. This ChIP-seq dataset has been generated using human cell lines (ENCODE Project Consortium, 2012) . A given REST ChIP-seq peak from ENCODE was considered indicative of REST binding if the associated cluster score was higher than 850 in the 'wgEncodeRegTfbsClusteredV2 0 table of the UCSC Table Browser . Even high score peaks were filtered out if the peaks were not located within an annotated gene or maximum 6 kb upstream of the transcription start site of a gene. We refer to the mouse orthologs of these human REST-binding genes as 'high-confidence REST targets' (Table  S2 ). This filtered set of REST-binding genes was considered applicable to the analysis of mouse data because the REST-binding RE1 motifs are conserved among vertebrates in 90% of the high-confidence REST target genes (Table S2 ). Potentially RFX-binding genes were identified in the mouse genome by searching for RFX1-binding motifs-like sequences in the 'Hub_186875_JasparTFBS' table using the UCSC Table Browser ( Khan et al., 2018) . The list of RFX1-binding motif-like sequences was filtered based on cluster score (cut-off: 400), conservation (> 0.4 mean conservation score in the '60-vertebrate Basewise Conservation by PhyloP' table), and location (±300 bp from a transcription start site). Potential RFX1-binding motifs that overlapped with coding regions of genes were filtered out because conservation in these regions is more likely to indicate the non-neutral evolution of a protein-coding sequence than that of a potential regulatory motif. The utricular RNA-seq data were analyzed for potential differences in alternative splicing and polyA site selection using the JunctionSeq tool (Hartley and Mullikin, 2016) . Adjusted p = 0.001 was selected as cut-off for significantly different exon usage in the JunctionSeq analysis. All potential splicing differences were tested by RT-PCR (see primers in Table S6 ). Uniprot keyword annotations of differentially expressed genes were identified using the DAVID software (Huang da et al., 2009 ). All genes expressed in E16 vestibular hair cells were used as the background gene set for the Uniprot keyword annotation analysis .
SAHA Treatment of Mice
SAHA was dissolved in DMSO and diluted 2-fold in Cremophor EL (Millipore). Just before the mice were injected, the DMSO/Cremphor EL solution of SAHA was diluted further in 0.9% NaCl. Rest +/DEx4 and WT mice were injected subcutaneously with 100 mg SAHA/kg body weight at P2, P4 and P5. In the control group, Rest +/DEx4 and WT mice were injected with the vehicle solution only. At P6, the morphology of the organ of Corti and the extent of H4 acetylation were evaluated as described in the 'Immunofluorescence and Histochemistry' section. Rest +/flEx4 ;Rosa +/CreERT2 mice were injected with a mixture of SAHA (100 mg/kg body weight) and (Z)-4-hydroxytamoxifen (33 mg/kg body weight) at P7, P8, and P9. From P10 to P15, the same mice were injected with SAHA only (150 mg/kg body weight/day). In the control groups, Rest
;Rosa +/CreERT2 mice were injected with (Z)-4-hydroxytamoxifen (33 mg/kg body weight/day at P7-9) or vehicle only. WT mice were also treated with the same regimen of SAHA, (Z)-4-hydroxytamoxifen, and vehicle solution than Rest
;Rosa +/CreERT2 mice. At P16, the ABR was measured to test the hearing thresholds of mice. Subsequently, the morphology of the organ of Corti or H4 acetylation was examined as described in the 'Immunofluorescence and Histochemistry' section.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented as individual data points, mean ± standard error of the mean (SEM), or median with minimum, maximum, 25 th , and 75
th percentile values, as indicated in the corresponding figure legends. The statistical methods applied are either indicated in the figure legend or described in the main text. Sample sizes were not determined a priori. RNA-seq data and Uniprot keyword annotations were analyzed using the DESeq2 software and the DAVID bioinformatics tool, respectively (see 'RNA Sequencing and Bioinformatics Analysis' section). scqRT-PCR data were analyzed using the SINGuLAR Analysis Toolset (Fluidigm) in R 3.0.2, as described in the 'Single Cell RT-PCR' section. All other data analyses were performed with GraphPad Prism version 7. For the datasets analyzed using GraphPad Prism, assumptions of normality were tested with the Shapiro-Wilk test and assumptions of equal variance with either the F-test (for two groups) or the Brown-Forsythe test (for three or more groups).
In cases where assumptions of normality and equal variance were not violated, parametric tests were used for the further analysis of datasets: the one-sample t test was used to compare the mean of one group to a hypothetical value; the unpaired Student's t test was used to compare the means of two groups; and one-way or two-way ANOVA was used (depending on the number of categorical independent variables) to compare the means of three or more groups. When ANOVA revealed significant findings, the Dunnett's post hoc test was used to compare the means of the test groups to the mean of a control group.
In the few cases where the assumption of equal variance (but not normality) was violated, Welch's t test was used to compare the means of two groups.
In cases where the assumption of normality (but not equal variance) was violated, non-parametric tests were used for the analysis of datasets: the one-sample Wilcoxon-signed rank test was used to compare the median of one group to a hypothetical value; and the Mann-Whitney test was used to compare the medians of two groups.
In cases where assumptions of both normality and equal variance were violated, one of two approaches was selected.
d Datasets presented in Figures 4E, 4F , and the right panel of Figure S6F were log2 transformed. Analyses of these log2 transformed data with the Shapiro-Wilk test and F-test revealed that assumptions of normality (but not equal variance) were violated. Therefore, following the log2 transformation the Mann-Whitney test was used to compare the medians of two groups. d Datasets presented in Figure 6G were analyzed using a parametric test (i.e., two-way ANOVA) without data transformation. In this figure, ceiling effects led to violations of normality and equal variance assumptions. Specifically, thresholds of 32 kHz sound-evoked ABRs were higher than the maximum tested sound pressure level (i.e., 90 dB) in two groups of Rest exon 4 deficient mice. In the context of Figure 6G , these ceiling effects increased the probability of type II error (false negative) but not the type I error (false positive).
In figure panels where multiple one-sample tests or two-group tests were used, the Benjamini-Hochberg procedure was applied to limit the false discovery rate (FDR) at 0.05, as indicated in the relevant figure legends. For gene enrichment analysis, Fisher's exact test was used.
All reported p values are two-tailed, and p < 0.05 is considered statistically significant unless otherwise specified. Numbers of animals and biological replicates of assays (n) are reported in the figure legends if a statistical test was used or individual data points are not shown in the corresponding figure. Replicates for each experiment are outlined here:
d Figure 1C is representative of images from 3 independent assays. In each assay, one E15.5 mouse/genotype (utricle sample) and one P0 mouse/genotype (all other samples) were used. RNA was pooled from the left and right utricles of each mouse. d Figures 1D and 1E represent data from 18 WT and 9 Rest +/DEx4 mice.
d Figure 1F represents data from 12 WT and 10 Rest +/DEx4 mice. d Figure 1H is representative of images of: 6 utricles from 3 E16 WT mice; 8 utricles from 4 P6 WT mice; 10 utricles from 5 E16 Rest +/DEx4 mice; and 14 utricles from 7 P6 Rest +/DEx4 mice.
d Figure 1I represents data from 5 mice/group. d Figures 1J and S3A are representative images of 10 inner ear preparations from 5 mice/group. d Figure 2A represents data for the number of affected and unaffected subjects indicated in the LMG2 family pedigree in Figure 2B . d Figure 3A represents data for two affected subjects from the LMG2 family and a control subject. The RT-PCR was repeated once (2 technical replicates). d Figure 3C is representative of images from 4 independent assays. d Figure 3G represents data from 4 independent assays. d Figures 4A and 4B represent RNA-seq data from the number of tissue samples and mice described in the 'RNA Sequencing and Bioinformatics Analysis' section of Method Details. d Figure 4D is representative of images of 14 utricles from 8 WT and 9 utricles from 6 Rest +/DEx4 mice. Figure 5A : Left panel is representative of images from 3 independent assays (one mouse/time point in each assay). Middle and right panels are representative of images from 2 independent assays (one sample/time point in each assay; 6-10 hearing or balance organs from 3-5 mice were pooled for each sample). d Figure 5C is representative of images of 6 cortical sections from 3 mice/time point (2 cortical sections/mouse/time point). d Figure 5D is representative of images of 10-12 inner ear sections from 3 mice/time point. d Figure 5E represents data from 3 mice/group. 1-3 organ of Corti-containing areas were analyzed in each section. Figure 5F represents data from: 159 non-HCs isolated from 5 P1 mice; 63 non-HCs isolated from 4 P7 mice; 20 OHCs isolated from 5 P1 mice; 19 OHCs isolated from 4 P7 mice; 9 IHCs isolated from 3 P1 mice; and 4 IHCs isolated from 2 P7 mice. d Figures 5G and 5H represent data from 10 non-HCs isolated from: 3 P1 mice; 10 non-HCs isolated from 3 P7 mice; 8 OHCs isolated from 3 P1 mice; 10 OHCs isolated from 3 P7 mice; 4 IHCs isolated from 3 P1 mice; and 4 IHCs isolated from 2 P7 mice. d Figure 6A is Figure 6D , the hair cell counts are the average for the two ears of each mouse. Figure 6G represents data from 8 mice in the 'Rest +/flEx4 ;Rosa +/CreERT2 + T + SAHA' group and 7 mice/group in all other groups.
ABR thresholds were determined for each mouse at each sound frequency indicated in the figure. d Figure S1B is representative of images from 2 independent assays. DNA from 2 WT mice and 3 Rest +/flNeoEx4 mice was analyzed in these assays (one DNA sample/mouse). d Figure S1C is representative of images from 3 independent assays. RNA from 3 WT and 4 Rest flEx4/flEx4 mice was analyzed in the 3 assays (one RNA sample/mouse were analyzed). d Figure S1D represents data from 3 WT and 4 Rest flEx4/flEx4 mice.
d Figure S1E is representative of images from 3 independent assays (one mouse/genotype/assay). d Figure S1F represents data from 4 mice/genotype/time point. d Figure S1G is representative of images of 4 organs of Corti from 2 mice/genotype. d Figure S1H is representative of images of 4 utricles from 2 mice/genotype. d Figure S1I is representative of images of 8 organs of Corti and 8 utricles from 4 mice. d Figure S2B is representative of images of: 6 utricles and 6 anterior cristae ampullaris from 3 E16 WT mice; 8 utricles and 8 anterior cristae ampullaris from 4 P6 WT mice; 10 utricles and 10 anterior cristae ampullaris from 5 E16 Rest +/DEx4 mice; and 14 utricles and 14 anterior cristae ampullaris from 7 P6 Rest +/DEx4 mice.
d Figures S2C and S2D represent data from the number of inner ears and mice indicated in the legend of Figure S2 . d Figure S3B is representative of images from 2 independent assays. In each assay, DNA samples from 2 WT, 3 Rest +/flEx4 ;-Rosa +/CreERT2 , and 3 'Rest +/flEx4 ;Rosa +/CreERT2 + T' mice were analyzed.
d Figure S3C is representative of images of 6 organs of Corti of 3 mice/genotype. d Figure S3D is representative of images of 4 solvent-incubated organ cultures and 5 Z-DEVD-FMK-incubated organ cultures (one culture/mouse/incubation condition). d Figure S3E represents data from: 4 organ cultures incubated with solvent; 5 organ cultures incubated with Z-DEVD-FMK; and 5 organ cultures incubated with Z-VAD-FMK (one organ culture/mouse/incubation condition). d Figure S3F is representative of images of 40 brain sections from 2 WT mice and 91 brain sections from 4 Rest +/DEx4 mice.
d Figure S3G is representative of images of 16 cortical sections from 4 mice/genotype (4 sections/mouse). d Figure S3H represents data from 4 mice/genotype (4 sections/mouse were analyzed). d Figure S3I represents data from 3 mice/genotype (2 sections/mouse were analyzed). d Figure S3J is representative of images of 61 sections from 4 WT mice and 58 sections from 4 Rest +/DEx4 mice.
d Figure S3K represents data from: 13 WT mice at P30; 3 WT mice at P130; 4 Rest +/-mice at P30; and 3 Rest +/-mice at P130.
d Figure S3M is representative of images of 3 technical replicates/primer pair. One human RNA sample per organ was used. d Figure S3N is representative of images from 2 independent assays. d Figure S4A is representative of a single assay/primer pair. d Figure S4C represents data from 3 mice/genotype (RNA was pooled from the left and right utricles and saccules of each mouse). d Figure S4G represents data from 5 independent assays.
d Figure S4H represents data from 3 mice/genotype at each time point (RNA was pooled from the left and right utricles and saccules of each mouse). d Figure S4I is representative of images of 4 utricles and 4 saccules from 2 'Rest +/flEx4 ;Rosa +/CreERT2 -T' mice, and of 6 utricles and 6 saccules from 3 'Rest +/flEx4 ;Rosa +/CreERT2 + T' mice.
d Figure S4J is representative of images of 6 utricles from 3 mice at P0 and 10 utricles from 5 mice at P16. d Figure S5A represents data from 3 independent assays/treatment condition. d Figure S5B is Figure S5E represents data from 3 independent samples/treatment condition (6-8 organ cultures from 3-4 mice were pooled to obtain a single sample). d Figure S6A represents data from 3 organ cultures/group (one organ culture/mouse/group). d Figure S6C is representative of images from 2 independent assays. DNA was isolated from 4 organ cultures (derived from 2 mice) to obtain a single sample. In the 2 assays, 2 samples per treatment condition were analyzed. d Figure 
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The accession number for the RNA-seq data reported in this paper is GEO: GSE111606. (D) . Organ cultures were exposed to FK228 (2 nM) or solvent twice (DIV1-1.5 and DIV3-3.5). Left panels: FK228-induced changes in gene expression. Right panels: FK228-induced changes in the expression of high-confidence REST targets. Numbers in parentheses indicate the percentage of differentially expressed genes that are upregulated by FK228. The names of differentially expressed genes are shown in Table S5 . ;Rosa +/CreERT2 mice. Tamoxifen (T) was added to cultures in the indicated combinations with SAHA (1 mM) and FK228 (2 nM). The incubation schedule is shown in (C) . The expected locations of IHCs (arrowheads) and OHCs (brackets) are indicated. Scale bar, 100 mm.
(legend continued on next page) (E) ;Rosa +/CreERT2 mice that were treated with the indicated combinations of tamoxifen (T) and SAHA or vehicle from P7 to P15 (see treatment protocol in Figure 6F ). Scale bar, 100 mm. 
